COVID-19 IgG/IgM Rapid Test Aytu Bioscience Inc.; L.B. Resources Ltd.; Zhejiang Orient Gene Biotech Co. Ltd. Aytu signed an exclusive distribution agreement for the right to commercialize a clinically validated and commercially used COVID-19 IgG/IgM Rapid Test, which was licensed from L.B. Resources Ltd., of Hong Kong, which had licensed North American rights from product developer Zhejiang; the test is a solid phase immunochromatographic assay and one of only a few tests used for coronavirus screening in China; as of March 19, 2020, Aytu extended its commercial rights to distribute and commercialize the COVID-19 test in the U.S., Canada and Mexico
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.